In April 2013, the FDA made a ruling that FMT could no longer be performed unless it was in the setting of an FDA approved clinical trial. Since July 2013, the FDA exercises enforcement discretion for fecal transplants (FMT) for Clostridium difficile infection that is resistant to standard therapy. This means that while the FDA considers FMT to be an investigational new drug and an experimental therapy, it is effectively allowing the use of FMT for refractory C diff infections outside of clinical trials. They made this allowance due to the capacity of FMT to resolve life-threatening infections.
If you have a C diff infection that has not resolved despite antibiotic treatments such as vancomycin, metronidazole (Flagyl) or fidaxomicin (Dificid), then you may be a candidate for FMT at this time.
At this time, we are unable to perform FMT for other conditions, however, we offer remote educational consultations to support you in doing home FMT safely and effectively. If you are local, you may come to see us in person and we can support you in screening your chosen donor, obtaining relevant medications and performing home FMT safely.
If you have questions about whether you are a candidate for treatment, please call our clinic at 503.928.7605 or